In contrast, Eotaxin‐3, IL‐31, IL‐23α, Gal‐3, IL‐7, TARC, VEGF, and MCP‐4 (CCL13) were significantly lower in CLL patients (Fig. 6B). This evidence concerns the gene IL23A and B-cell chronic lymphocytic leukemia.